Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma

详细信息    查看全文

• 作者：Caryn M. St. Clair MD ; Ane Gerda Z. Eriksson MD…
• 刊名：Annals of Surgical Oncology
• 出版年：2016
• 出版时间：May 2016
• 年：2016
• 卷：23
• 期：5
• 页码：1653-1659
• 全文大小：505 KB
• 参考文献：1.Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.CrossRef PubMed
  2.Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60:2035–41.CrossRef PubMed
  3.Kang S, Kang WD, Chung HH, et al. Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean Gynecologic Oncology Group study. J Clin Oncol. 2012;30:1329–34.CrossRef PubMed
  4.Quinlivan JA, Petersen RW, Nicklin JL. Accuracy of frozen section for the operative management of endometrial cancer. BJOG. 2001;108:798–803.PubMed
  5.Case AS, Rocconi RP, Straughn JM, et al. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet Gyncol. 2006;108:1375–79.CrossRef
  6.Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000;182:1506–19.CrossRef PubMed
  7.Dowdy SC, Aletti G, Cliby WA, Podratz KC, Mariani A. Extra-peritoneal laparoscopic para-aortic lymphadenectomy: a prospective cohort study of 293 patients with endometrial cancer. Gynecol Oncol . 2008;111:418–24.CrossRef PubMed PubMedCentral
  8.Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK; ASTEC study group. Efficacy of systemic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125–36.CrossRef PubMed
  9.Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707–16.CrossRef PubMed
  10.Barlin JN, Zhou Q, St. Clair CM, et al. Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees. Gynecol Oncol. 2013;130:452–56.CrossRef PubMed PubMedCentral
  11.Barlin JN, Khoury-Collado F, Kim CH, et al. The importance of applying a sentinel lymph node algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol. 2012;125:531–35.CrossRef PubMed
  12.Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25:3657–63.CrossRef PubMed
  13.Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609.CrossRef PubMed
  14.Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.CrossRef PubMed PubMedCentral
  15.Siegel RL, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.CrossRef PubMed
  16.Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. Philadelphia, PA: Springer; 2002.CrossRef
  17.Andersson Y, Frisell J, Sylvan M, de Boniface J, Bergkvist L. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol. 2010;28:2868–73.CrossRef PubMed
  18.Kim CH, Soslow RA, Park KJ, et al. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer. 2013;23:964–70.CrossRef PubMed PubMedCentral
  19.Han G, Lim D, Leitao MM Jr, Abu-Rustum NR, Soslow RA. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade 1 endometrioid carcinoma. Histopathology. 2014;64:389–98.CrossRef PubMed
  20.Jewell EL, Huang JJ, Abu-Rustum NR, et al. Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malingnancies. Gynecol Oncol. 2014;133:274–77.CrossRef PubMed
  21.Plante M, Touhami O, Trihn XB, et al. Sentinel node mapping with indocyanine green and endoscopic near infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature. Gynecol Oncol. 2015;137:443–47.CrossRef PubMed
  22.Todo Y, Kato H, Okamoto K, Minobe S, Yamashiro K, Sakuragi N. Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer. J Gynecol Oncol. 2016;27(1):e1.CrossRef PubMed PubMedCentral
  23.Touhami O, Trihn XB, Gregoire J, et al. Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph nodes (SLN) metastasis in endometrial cancer. Gynecol Oncol. 2015;138:41–45.CrossRef PubMed
  
• 作者单位：Caryn M. St. Clair MD (1)
  Ane Gerda Z. Eriksson MD (1)
  Jennifer A. Ducie MD (1)
  Elizabeth L. Jewell MD (1) (2)
  Kaled M. Alektiar MD (3)
  Martee L. Hensley MD (4) (5)
  Robert A. Soslow MD (6) (7)
  Nadeem R. Abu-Rustum MD (1) (2)
  Mario M. Leitao Jr. MD (1) (2)
  
  1. Department of Surgery, Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  2. Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA
  3. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  4. Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  5. Department of Medicine, Weill Cornell Medical College, New York, NY, USA
  6. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  7. Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA
  
• 刊物主题：Surgical Oncology; Oncology; Surgery;
• 出版者：Springer US
• ISSN：1534-4681

文摘

Purpose The aim of this study was to characterize treatment patterns and oncologic outcomes in patients with low-volume lymph node metastasis (isolated tumor cells [ITCs] and micrometastasis [MM]) discovered during sentinel lymph node (SLN) mapping for endometrial carcinoma.